welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!

Sarepta Therapeutics Announces Third Year of Route 79, The Duchenne Scholarship Program


Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that the website for Route 79, The Duchenne Scholarship Program, is officially open and accepting applications. Academic scholarships of up to $5,000 will be awarded to up to 20 individuals chosen by an independent committee of Duchenne community members based on an applicant’s community involvement, personal essay and recommendation letter. The Route 79 program is designed to help students with Duchenne pursue their post-secondary educational goals.

Sarepta Therapeutics Announces Third Year Of Route 79, The Duchenne Scholarship Program